Ana Newton, Ph.D.

Ana S. Newton, Ph.D. was a postdoctoral researcher at the Jorgensen Lab in the Department of Chemistry at Yale University., where she developed small inhibitors to treat cancer and HIV using both computational and synthetic skills. She lead two collaborative research projects to design potent small molecule inhibitors of DNMT3B, a protein whose inhibition has been shown to reduce or eliminate cancer growth, and CXCR4, a G-protein-coupled receptor associated with HIV. Dr. Newton holds a Ph.D. in Medicinal Chemistry and a B.S. in Chemistry from the University of Lisbon.